FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016505983> ?p ?o ?g. }

• W2016505983 endingPage "284" @default.
• W2016505983 startingPage "280" @default.
• W2016505983 abstract "Transfusion MedicineVolume 21, Issue 4 p. 280-284 Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy A. Giampaolo, A. Giampaolo Department of Haematology, Oncology and Molecular Medicine These authors contributed equally to this work. Search for more papers by this authorF. Abbonizio, F. Abbonizio Department of Haematology, Oncology and Molecular Medicine These authors contributed equally to this work. Search for more papers by this authorM. Puopolo, M. Puopolo Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, ItalySearch for more papers by this authorR. Arcieri, R. Arcieri Federation of Haemophiliac AssociationsSearch for more papers by this authorP. M. Mannucci, P. M. Mannucci Scientific Direction, IRCCS Ca’ Granda Foundation, Maggiore Policlinico Hospital, Milan, ItalySearch for more papers by this authoron behalf of the Italian Association of Haemophilia Centres (AICE), on behalf of the Italian Association of Haemophilia Centres (AICE) Complete list of co-authors is provided in Appendix. Search for more papers by this authorH. J. Hassan, Corresponding Author H. J. Hassan Department of Haematology, Oncology and Molecular MedicineDr Hamisa Jane Hassan, Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy.Tel.: +39 06 49903608; fax: +39 06 49902100;e-mail: [email protected]Search for more papers by this author A. Giampaolo, A. Giampaolo Department of Haematology, Oncology and Molecular Medicine These authors contributed equally to this work. Search for more papers by this authorF. Abbonizio, F. Abbonizio Department of Haematology, Oncology and Molecular Medicine These authors contributed equally to this work. Search for more papers by this authorM. Puopolo, M. Puopolo Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, ItalySearch for more papers by this authorR. Arcieri, R. Arcieri Federation of Haemophiliac AssociationsSearch for more papers by this authorP. M. Mannucci, P. M. Mannucci Scientific Direction, IRCCS Ca’ Granda Foundation, Maggiore Policlinico Hospital, Milan, ItalySearch for more papers by this authoron behalf of the Italian Association of Haemophilia Centres (AICE), on behalf of the Italian Association of Haemophilia Centres (AICE) Complete list of co-authors is provided in Appendix. Search for more papers by this authorH. J. Hassan, Corresponding Author H. J. Hassan Department of Haematology, Oncology and Molecular MedicineDr Hamisa Jane Hassan, Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy.Tel.: +39 06 49903608; fax: +39 06 49902100;e-mail: [email protected]Search for more papers by this author First published: 30 March 2011 https://doi.org/10.1111/j.1365-3148.2011.01074.xCitations: 5 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Berntorp, E., Boulyjenkov, V., Brettler, D. et al. (1995) Modern treatment of haemophilia. Bulletin of the World Health Organization, 73, 691–701. Biss, T.T., Chan, A.K., Blanchette, V.S., Iwenofu, L.N., McLimont, M., Carcao, M.D., Association of Hemophilia Clinic Directors of Canada (AHCDC) & Canadian Association of Nurses in Hemophilia Care (CANHC). (2008) The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey. Haemophilia, 14, 923–930. Manco-Johnson, M.J., Abshire, T.C., Shapiro, A.D. et al. (2007) Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. The New England Journal of Medicine, 357, 535–544. Mannucci, P.M., Schutgens, R.E.G., Santagostino, E. & Mauser-Bunschoten, E.P. (2009) How I treat age-related morbidities in elderly persons with hemophilia. Blood, 114, 5256–5263. Ofosu, F.A., Freedman, J. & Semple, J.W. (2008) Plasma-derived biological medicines used to promote haemostasis. Thrombosis and Haemostasis, 99, 851–862. Roosendaal, G. & Lafeber, F. (2007) Prophylactic treatment for prevention of joint disease in hemophilia – cost versus benefit. The New England Journal of Medicine, 357, 603–605. Santagostino, E., Mannucci, P.M. & Bianchi Bonomi, A. (2000) Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy. Haemophilia, 6, 1–10. Stonebraker, J.S., Brooker, M., Amand, R.E., Farrugia, A. & Srivastava, A. (2010) A study of reported factor VIII use around the world. Haemophilia, 16, 33–46. Tagariello, G., Iorio, A., Santagostino, E. et al. (2009) Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. Blood, 114, 779–784. United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO). UK Bleeding Disorder Statistics for 2007. Annual Report (2008). Available at www.ukhcdo.org (Accessed 8/4/10). World Federation of Hemophilia. (2008) Report on The Annual Global Survey 2007. WFH, Montreal, Canada. Available at http://www.wfh.org/2/docs/Publications/Statistics/2007-Survey-Report.pdf (Accessed 8/4/10). World Health Organization. (2002) Delivery of treatment for haemophilia. Report of a Joint WHO/WFH/ISTH Meeting. WHO, London, United Kingdom. Available at http://whqlibdoc.who.int/hq/2002/WHO_WFH_ISTH_WG_02.6.pdf (Accessed 8/4/10). Citing Literature Volume21, Issue4August 2011Pages 280-284 ReferencesRelatedInformation" @default.
• W2016505983 created "2016-06-24" @default.
• W2016505983 creator A5006734763 @default.
• W2016505983 creator A5026541993 @default.
• W2016505983 creator A5029083560 @default.
• W2016505983 creator A5046552125 @default.
• W2016505983 creator A5065489740 @default.
• W2016505983 creator A5090928454 @default.
• W2016505983 date "2011-03-30" @default.
• W2016505983 modified "2023-10-03" @default.
• W2016505983 title "Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy" @default.
• W2016505983 cites W2018336328 @default.
• W2016505983 cites W2018471236 @default.
• W2016505983 cites W2028252035 @default.
• W2016505983 cites W2038056060 @default.
• W2016505983 cites W2078332762 @default.
• W2016505983 cites W2111802082 @default.
• W2016505983 cites W2154252930 @default.
• W2016505983 cites W2167801052 @default.
• W2016505983 doi "https://doi.org/10.1111/j.1365-3148.2011.01074.x" @default.
• W2016505983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21733006" @default.
• W2016505983 hasPublicationYear "2011" @default.
• W2016505983 type Work @default.
• W2016505983 sameAs 2016505983 @default.
• W2016505983 citedByCount "7" @default.
• W2016505983 countsByYear W20165059832013 @default.
• W2016505983 countsByYear W20165059832014 @default.
• W2016505983 countsByYear W20165059832019 @default.
• W2016505983 countsByYear W20165059832022 @default.
• W2016505983 countsByYear W20165059832023 @default.
• W2016505983 crossrefType "journal-article" @default.
• W2016505983 hasAuthorship W2016505983A5006734763 @default.
• W2016505983 hasAuthorship W2016505983A5026541993 @default.
• W2016505983 hasAuthorship W2016505983A5029083560 @default.
• W2016505983 hasAuthorship W2016505983A5046552125 @default.
• W2016505983 hasAuthorship W2016505983A5065489740 @default.
• W2016505983 hasAuthorship W2016505983A5090928454 @default.
• W2016505983 hasBestOaLocation W20165059831 @default.
• W2016505983 hasConcept C126322002 @default.
• W2016505983 hasConcept C143998085 @default.
• W2016505983 hasConcept C187212893 @default.
• W2016505983 hasConcept C194409129 @default.
• W2016505983 hasConcept C2778385053 @default.
• W2016505983 hasConcept C2780014101 @default.
• W2016505983 hasConcept C512399662 @default.
• W2016505983 hasConcept C71924100 @default.
• W2016505983 hasConcept C79592252 @default.
• W2016505983 hasConceptScore W2016505983C126322002 @default.
• W2016505983 hasConceptScore W2016505983C143998085 @default.
• W2016505983 hasConceptScore W2016505983C187212893 @default.
• W2016505983 hasConceptScore W2016505983C194409129 @default.
• W2016505983 hasConceptScore W2016505983C2778385053 @default.
• W2016505983 hasConceptScore W2016505983C2780014101 @default.
• W2016505983 hasConceptScore W2016505983C512399662 @default.
• W2016505983 hasConceptScore W2016505983C71924100 @default.
• W2016505983 hasConceptScore W2016505983C79592252 @default.
• W2016505983 hasIssue "4" @default.
• W2016505983 hasLocation W20165059831 @default.
• W2016505983 hasLocation W20165059832 @default.
• W2016505983 hasOpenAccess W2016505983 @default.
• W2016505983 hasPrimaryLocation W20165059831 @default.
• W2016505983 hasRelatedWork W2016505983 @default.
• W2016505983 hasRelatedWork W2060649759 @default.
• W2016505983 hasRelatedWork W2063831109 @default.
• W2016505983 hasRelatedWork W2172269466 @default.
• W2016505983 hasRelatedWork W2478422075 @default.
• W2016505983 hasRelatedWork W3109718969 @default.
• W2016505983 hasRelatedWork W4200085715 @default.
• W2016505983 hasRelatedWork W4235487475 @default.
• W2016505983 hasRelatedWork W4249703122 @default.
• W2016505983 hasRelatedWork W4255546945 @default.
• W2016505983 hasVolume "21" @default.
• W2016505983 isParatext "false" @default.
• W2016505983 isRetracted "false" @default.
• W2016505983 magId "2016505983" @default.
• W2016505983 workType "article" @default.